OSIMERT is used for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive (NSCLC) which have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy, as determined by an approved test.
Il contenuto caricato verrà spostato in questo album appena creato. Devi crea un account o l se desideri modificare questo album in seguito.
__privacy_notes__